Echo IQ (ASX:EIQ) has entered into a strategic partnership and integration agreements with two US healthcare technology providers, ScImage and MedAxiom, to expand the distribution of its artificial intelligence-powered cardiology tool, EchoSolv AS, according to a Monday filing with the Australian bourse.
The integration will provide physicians with access to advanced diagnostics via ScImage's image management platform, the filing said.
Shares of the company fell 3% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.